Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

4094 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-01

Study Completion Date

2035-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants.

The study is planned to begin in May 2025 and will finalize the data collection for the entire population by June 2026. During this time, participants will be categorized based on CKM staging. The follow-up phase will continue until 2035.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CArdioMetabolism and Atherosclerotic PlaqUe progreSsion

NCT05117424

Coronary Artery Disease Diabetes Mellitus, Type 2 Dyslipidemias +2 more

RECRUITING

Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)

NCT07205510

Sarcopenia Metabolic Diseases All-cause Mortality +2 more

RECRUITING

Metabolic Syndrome and Related Diseases in Healthcare Workers

NCT06543706

Metabolic Syndrome X Diabetes Mellitus Type 2 Hypertension +4 more

COMPLETED

PDR and SKYD of Dyslipidemia's Characteristics From the Oxidative Stress Enhancement Caused by Inhibition of Serine Metabolic Pathway

NCT04909489

Traditional Chinese Medicine Dyslipidemias Syndrome

UNKNOWN

Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery.

NCT06645730

Metabolic Syndrome

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Between 2016 and 2017, Shanghai Changzheng Hospital conducted a random stratified sampling in 10 communities in Shanghai among individuals aged 18-65 years who had resided in the community for more than six months. Pregnant women, individuals with fractures, severe mental disorders or dementia, bedridden individuals, and those with hepatitis, tuberculosis, AIDS, other infectious diseases, severe liver or kidney dysfunction, and other serious life-threatening diseases were excluded. The Shanghai Thyroid autOimmuNity: an Epidemiological research (STONE) cohort was established. Trained physicians collected multidimensional baseline health data from more than 4,000 Shanghai community residents through questionnaires, structured interviews, physical examinations, and clinical tests. The data included demographic information (gender, age, education level, marital status, employment status, income level, etc.), lifestyle and psychological status (smoking history, alcohol consumption history, dietary habits, sleep, physical activity, etc.), physical examination indicators (height, weight, waist circumference, blood pressure), comprehensive metabolic indicators (complete blood count, liver and kidney function, thyroid function, glucose metabolism indicators, lipid metabolism indicators, tumor immunity, hormone levels), and ultrasound imaging data (abdominal ultrasound, thyroid ultrasound, carotid ultrasound, bone density).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Diabetes Obesity and Overweight Hypertension Dyslipidemia Thyroid Diseases Bone Metabolism Disorder Chronic Kidney Disease(CKD) Cardiovascular Diseases (CVD) Cardiovascular-kidney-metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The 4,094 residents of Shanghai communities who have been enrolled in the STONE cohort.
2. Individuals who completed the baseline questionnaire survey, physical examination, and related clinical tests between 2016 and 2017, with complete data records.
3. Willingness to participate in this follow-up study and provision of informed consent.

Exclusion Criteria

1. Participants who have moved away from their original community and have been living elsewhere for more than two years.
2. Participants whose contact information has changed or become invalid, resulting in loss of contact (those who remain uncontactable after three attempts to reach out).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes